peptide elongation factor 2 has been researched along with Osteoarthritis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chien, CT; Hsieh, CH; Huang, LH; Jiang, CC; Ko, CJ; Lee, CW; Yu, CJ | 1 |
1 trial(s) available for peptide elongation factor 2 and Osteoarthritis
| Article | Year |
|---|---|
Proteomic analysis of osteoarthritic chondrocyte reveals the hyaluronic acid-regulated proteins involved in chondroprotective effect under oxidative stress.
Topics: Adult; Aged; Aged, 80 and over; Annexin A1; Antioxidants; Cell Death; Chondrocytes; Female; Humans; Hyaluronic Acid; Hydrogen Peroxide; Male; Middle Aged; Osteoarthritis; Oxidants; Oxidative Stress; Peptide Elongation Factor 2; Proteomics; Viscosupplements | 2014 |